Evidence map›Paper›PMID 37250788›Full record

ArticleiScience2023

Miquel de Homdedeu, Lidia Sanchez-Moral, Concepció Violán, Neus Ràfols, Dan Ouchi, Berta Martín, Miguel A Peinado, Alhelí Rodríguez-Cortés, Marta Arch-Sisquella, Daniel Perez-Zsolt and 12 more

Open access · goldAbstract read
In one paragraph

Article in iScience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Frontiers in cellular and infection microbiology · 2026
    Article
  2. Article
  3. Safety and immunomodulatory efficacy of heat-killedFrontiers in veterinary science · 2025
    Article
  4. Article
  5. Heat-killediScience · 2024
    Article
  6. Frontiers in immunology · 2024
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 6 institutions in 1 country.

Miquel de HomdedeuInnate Immunity Group, Germans Trias i Pujol Research Institute (IGTP), 08916 Badalona, Spain.
Lidia Sanchez-MoralInnate Immunity Group, Germans Trias i Pujol Research Institute (IGTP), 08916 Badalona, Spain.
Concepció ViolánJordi Gol University Research Institute in Primary Care, 08007 Barcelona, Spain.
Neus RàfolsInnate Immunity Group, Germans Trias i Pujol Research Institute (IGTP), 08916 Badalona, Spain.
Dan OuchiJordi Gol University Research Institute in Primary Care, 08007 Barcelona, Spain.
Berta MartínProgram of Predictive and Personalized Medicine of Cancer, Germans Trias i Pujol Research Institute (PMPPC-IGTP), 08916 Badalona, Spain.
Miguel A PeinadoProgram of Predictive and Personalized Medicine of Cancer, Germans Trias i Pujol Research Institute (PMPPC-IGTP), 08916 Badalona, Spain.
Alhelí Rodríguez-CortésDepartment of Pharmacology, Toxicology, and Therapeutics, Veterinary Faculty, Autonomous University of Barcelona, 08193 Bellaterra, Spain.
Marta Arch-SisquellaExperimental Tuberculosis Unit, Germans Trias i Pujol Research Institute (IGTP), 08916 Badalona, Spain.
Daniel Perez-ZsoltIrsiCaixa AIDS Research Institute, 08916 Badalona, Spain.
Jordana Muñoz-BasagoitiIrsiCaixa AIDS Research Institute, 08916 Badalona, Spain.
Nuria Izquierdo-UserosIrsiCaixa AIDS Research Institute, 08916 Badalona, Spain.
Betlem SalvadorJordi Gol University Research Institute in Primary Care, 08007 Barcelona, Spain.
Joan MatlloDepartment of Prevention and Risks, Germans Trias i Pujol University Hospital, Northern Metropolitan Territorial Management, Catalan Health Institute, 08916 Badalona, Spain.
Sergi López-SerranoJoint IRTA-UAB Research Unit in Animal Health, Animal Health Research Center (CReSA), Autonomous University of Barcelona (UAB), 08193 Bellaterra, Spain.
Joaquim SegalésJoint IRTA-UAB Research Unit in Animal Health, Animal Health Research Center (CReSA), Autonomous University of Barcelona (UAB), 08193 Bellaterra, Spain.
Cristina VilaplanaExperimental Tuberculosis Unit, Germans Trias i Pujol Research Institute (IGTP), 08916 Badalona, Spain.
Pere Torán-MonserratJordi Gol University Research Institute in Primary Care, 08007 Barcelona, Spain.
Rosa MorrosJordi Gol University Research Institute in Primary Care, 08007 Barcelona, Spain.
Ramon MonfàJordi Gol University Research Institute in Primary Care, 08007 Barcelona, Spain.
Maria-Rosa SarriasInnate Immunity Group, Germans Trias i Pujol Research Institute (IGTP), 08916 Badalona, Spain.
Pere-Joan CardonaExperimental Tuberculosis Unit, Germans Trias i Pujol Research Institute (IGTP), 08916 Badalona, Spain.
Universitat Autònoma de Barcelona · ESInstitut Universitari d'Investigació en Atenció Primària Jordi Gol · ESInstitut d'Investigació en Ciències de la Salut Germans Trias i Pujol · ESIrsiCaixa · ESInstitute of Predictive and Personalized Medicine of Cancer · ESCentre for Biomedical Network Research on Rare Diseases · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic posed a global health crisis, with new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants weakening vaccine-driven protection. Trained immunity could help tackle COVID-19 disease. Our objective was to analyze whether heat-killed

Indexed as

Biological sciencesImmunologyMicrobiologyMolecular biology

Identifiers

PMID37250788
PMCPMC10182650
OpenAlexW4376612939

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.